Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N D Hall

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Clinical and Experimental Immunology|May 1, 1995
Detection of anti-topoisomerase I antibodies using a full length human topoisomerase I recombinant protein purified from a baculovirus expression systemJ Whyte, W C Earnshaw, J J Champoux, et al.
Immunology|December 14, 1999
Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signallingL S Walker, J D McLeod, G Boulougouris, et al.
Annals of the Rheumatic Diseases|October 1, 1989
Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosusN J Goulding, M R Podgorski, N D Hall, et al.
British Journal of Rheumatology|February 1, 1990
Factor VIII related antigen in connective tissue disease patients and relativesJ P James, T R Stevens, N D Hall, et al.
Lancet (London, England)|January 1, 1979
Infection with E.B. virus and rheumatoid arthritisC J Elson, D H Crawford, R C Bucknall, et al.
Rheumatology (Oxford, England)|August 22, 2000
Class II MHC antigens in early rheumatoid arthritis in Bath (UK) and Madrid (Spain)A Balsa, N J Minaur, D Pascual-Salcedo, et al.
British Journal of Rheumatology|October 1, 1989
HLA-DO-related restriction fragment length polymorphisms in rheumatoid arthritis: evidence for a link with disease expressionD M Sansom, S N Amin, J L Bidwell, et al.
British Journal of Rheumatology|April 1, 1989
Thymopentin (TP-5) in the treatment of rheumatoid arthritisB K Kantharia, N J Goulding, N D Hall, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Clinical and Experimental Immunology|May 1, 1995
Detection of anti-topoisomerase I antibodies using a full length human topoisomerase I recombinant protein purified from a baculovirus expression systemJ Whyte, W C Earnshaw, J J Champoux, et al.
Immunology|December 14, 1999
Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signallingL S Walker, J D McLeod, G Boulougouris, et al.
Annals of the Rheumatic Diseases|October 1, 1989
Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosusN J Goulding, M R Podgorski, N D Hall, et al.
British Journal of Rheumatology|February 1, 1990
Factor VIII related antigen in connective tissue disease patients and relativesJ P James, T R Stevens, N D Hall, et al.
Lancet (London, England)|January 1, 1979
Infection with E.B. virus and rheumatoid arthritisC J Elson, D H Crawford, R C Bucknall, et al.
Rheumatology (Oxford, England)|August 22, 2000
Class II MHC antigens in early rheumatoid arthritis in Bath (UK) and Madrid (Spain)A Balsa, N J Minaur, D Pascual-Salcedo, et al.
British Journal of Rheumatology|October 1, 1989
HLA-DO-related restriction fragment length polymorphisms in rheumatoid arthritis: evidence for a link with disease expressionD M Sansom, S N Amin, J L Bidwell, et al.
British Journal of Rheumatology|April 1, 1989
Thymopentin (TP-5) in the treatment of rheumatoid arthritisB K Kantharia, N J Goulding, N D Hall, et al.
Pageof 7